{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:43:46Z","timestamp":1761709426817,"version":"3.41.0"},"reference-count":46,"publisher":"Pharmaceutical Society of Japan","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b17-00210","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T22:16:08Z","timestamp":1512080168000},"page":"2061-2067","source":"Crossref","is-referenced-by-count":9,"title":["Augmented Contractility to Noradrenaline in Femoral Arteries from the Otsuka Long-Evans Tokushima Fatty Rat, a Model of Type 2 Diabetes"],"prefix":"10.1248","volume":"40","author":[{"given":"Shota","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maika","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumiko","family":"Taguchi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuneo","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Physiology and Morphology, Institute of Medicinal Chemistry, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur. Heart J.<\/i>, 34<\/b>, 2444\u20132452 (2013)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lathief S, Inzucchi SE. Approach to diabetes management in patients with CVD. Trends Cardiovasc. Med.<\/i>, 26<\/b>, 165\u2013179 (2016).","DOI":"10.1016\/j.tcm.2015.05.005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Rhee SY, Kim YS. Peripheral arterial disease in patients with type 2 diabetes mellitus. Diabetes Metab. J.<\/i>, 39<\/b>, 283\u2013290 (2015).","DOI":"10.4093\/dmj.2015.39.4.283"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Utsunomiya K. Treatment strategy for type 2 diabetes from the perspective of systemic vascular protection and insulin resistance. Vasc. Health Risk Manag.<\/i>, 8<\/b>, 429\u2013436 (2012).","DOI":"10.2147\/VHRM.S32357"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Schaper NC, Nabuurs-Franssen MH, Huijberts MS. Peripheral vascular disease and type 2 diabetes mellitus. Diabetes Metab. Res. Rev.<\/i>, 16<\/b> (Suppl. 1), S11\u2013S15 (2000).","DOI":"10.1002\/1520-7560(200009\/10)16:1+<::AID-DMRR112>3.0.CO;2-V"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Jude EB, Eleftheriadou I, Tentolouris N. Peripheral arterial disease in diabetes\u2014a review. Diabet. Med.<\/i>, 27<\/b>, 4\u201314 (2010).","DOI":"10.1111\/j.1464-5491.2009.02866.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Faglia E, Caravaggi C, Marchetti R, Mingardi R, Morabito A, Piaggesi A, Uccioli L, Ceriello A, SCAR (SCreening for ARteriopathy) Study Group. Screening for peripheral arterial disease by means of the ankle-brachial index in newly diagnosed Type 2 diabetic patients. Diabet. Med.<\/i>, 22<\/b>, 1310\u20131314 (2005).","DOI":"10.1111\/j.1464-5491.2005.01612.x"},{"key":"8","unstructured":"8) Prompers L, Schaper N, Apelqvist J, Edmonds M, Jude E, Mauricio D, Uccioli L, Urbancic V, Bakker K, Holstein P, Jirkovska A, Piaggesi A, Ragnarson-Tennvall G, Reike H, Spraul M, Van Acker K, Van Baal J, Van Merode F, Ferreira I, Huijberts M. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia<\/i>, 51<\/b>, 747\u2013755 (2008)."},{"key":"9","unstructured":"9) Aiello A, Anichini R, Brocco E, Caravaggi C, Chiavetta A, Cioni R, Da Ros R, De Feo ME, Ferraresi R, Florio F, Gargiulo M, Galzerano G, Gandini R, Giurato L, Graziani L, Mancini L, Manzi M, Modugno P, Setacci C, Uccioli L, Italian Society of Diabetes, Italian Society of Radiology, Italian Society of Vascular Endovascular Surgery. Treatment of peripheral arterial disease in diabetes: a consensus of the Italian Societies of Diabetes (SID, AMD), Radiology (SIRM) and Vascular Endovascular Surgery (SICVE). Nutr. Metab. Cardiovasc. Dis.<\/i>, 24<\/b>, 355\u2013369 (2014)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hong YH, Betik AC, Premilovac D, Dwyer RM, Keske MA, Rattigan S, McConell GK. No effect of NOS inhibition on skeletal muscle glucose uptake during in situ<\/i> hindlimb contraction in healthy and diabetic Sprague-Dawley rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.<\/i>, 308<\/b>, R862\u2013R871 (2015).","DOI":"10.1152\/ajpregu.00412.2014"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lu X, Bean JS, Kassab GS, Rekhter MD. Protein kinase C inhibition ameliorates functional endothelial insulin resistance and vascular smooth muscle cell hypersensitivity to insulin in diabetic hypertensive rats. Cardiovasc. Diabetol.<\/i>, 10<\/b>, 48 (2011).","DOI":"10.1186\/1475-2840-10-48"},{"key":"12","unstructured":"12) Mart\u00ednez AC, Hern\u00e1ndez M, Novella S, Mart\u00ednez MP, Pag\u00e1n RM, Hermenegildo C, Garc\u00eda-Sacrist\u00e1n A, Prieto D, Benedito S. Diminished neurogenic femoral artery vasoconstrictor response in a Zucker obese rat model: differential regulation of NOS and COX derivatives. PLOS ONE<\/i>, 9<\/b>, e106372 (2014)."},{"key":"13","unstructured":"13) Reynolds LJ, Credeur DP, Manrique C, Padilla J, Fadel PJ, Thyfault JP. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1. J. Appl. Physiol.<\/i>, 122<\/b>, 38\u201347 (2017)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wheal AJ, Cipriano M, Fowler CJ, Randall MD, O\u2019Sullivan SE. Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation. J. Pharmacol. Exp. Ther.<\/i>, 351<\/b>, 457\u2013466 (2014).","DOI":"10.1124\/jpet.114.217125"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kobayashi T, Nemoto T, Ishida K, Taguchi K, Matsumoto T, Kamata K. Involvement of CaM kinase II in the impairment of endothelial function and eNOS activity in aortas of Type 2 diabetic rats. Clin. Sci.<\/i>, 123<\/b>, 375\u2013386 (2012).","DOI":"10.1042\/CS20110621"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Matsumoto T, Nakayama N, Ishida K, Kobayashi T, Kamata K. Eicosapentaenoic acid improves imbalance between vasodilator and vasoconstrictor actions of endothelium-derived factors in mesenteric arteries from rats at chronic stage of type 2 diabetes. J. Pharmacol. Exp. Ther.<\/i>, 329<\/b>, 324\u2013334 (2009).","DOI":"10.1124\/jpet.108.148718"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Taguchi K, Hida M, Matsumoto T, Kobayashi T. Resveratrol ameliorates clonidine-induced endothelium-dependent relaxation involving Akt and endothelial nitric oxide synthase regulation in type 2 diabetic mice. Biol. Pharm. Bull.<\/i>, 38<\/b>, 1864\u20131872 (2015).","DOI":"10.1248\/bpb.b15-00403"},{"key":"18","unstructured":"18) Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi N, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes<\/i>, 41<\/b>, 1422\u20131428 (1992)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Katsuda Y, Ohta T, Miyajima K, Kemmochi Y, Sasase T, Tong B, Shinohara M, Yamada T. Diabetic complications in obese type 2 diabetic rat model. Exp. Anim.<\/i>, 63<\/b>, 121\u2013132 (2014).","DOI":"10.1538\/expanim.63.121"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Kikuchi C, Kajikuri J, Hori E, Nagami C, Matsunaga T, Kimura K, Itoh T. Aortic superoxide production at the early hyperglycemic stage in a rat type 2 diabetes model and the effects of pravastatin. Biol. Pharm. Bull.<\/i>, 37<\/b>, 996\u20131002 (2014).","DOI":"10.1248\/bpb.b13-00975"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Matsumoto T, Kobayashi T, Wachi H, Seyama Y, Kamata K. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Atherosclerosis<\/i>, 192<\/b>, 15\u201324 (2007).","DOI":"10.1016\/j.atherosclerosis.2006.06.005"},{"key":"22","unstructured":"22) Matsumoto T, Watanabe S, Ando M, Yamada K, Iguchi M, Taguchi K, Kobayashi T. Diabetes and age-related differences in vascular functions or renal artery: Possible involvement of endoplasmic reticulum stress. Rejuvenation Res.<\/i>, 19<\/b>, 41\u201352 (2016)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nemoto S, Taguchi K, Matsumoto T, Kamata K, Kobayashi T. Pravastatin normalizes ET-1-indced contraction in the aorta of type 2 diabetic OLETF rats by suppressing the KSR1\/ERK complex. Am. J. Physiol. Heart Circ. Physiol.<\/i>, 303<\/b>, H893\u2013H902 (2012).","DOI":"10.1152\/ajpheart.01128.2011"},{"key":"24","unstructured":"24) Kawano K, Hirashima T, Mori S, Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res. Clin. Pract.<\/i>, 24<\/b> (Suppl.), S317\u2013S320 (1994)."},{"key":"25","unstructured":"25) Matsumoto T, Watanabe S, Iguchi M, Ando M, Oda M, Nagata M, Yamada K, Taguchi K, Kobayashi T. Mechanisms underlying enhanced noradrenaline-induced femoral arterial contractions of spontaneously hypertensive rats: Involvement of endothelium-derived factors and cyclooxygenese-derived prostanoids. Biol. Pharm. Bull.<\/i>, 39<\/b>, 384\u2013393 (2016)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Watanabe S, Matsumoto T, Ando M, Kobayashi S, Iguchi M, Taguchi K, Kobayashi T. Effect of long-term diabetes on serotonin-mediated contraction in carotid arteries from streptozotocin-induced diabetic male and female rats. Biol. Pharm. Bull.<\/i>, 39<\/b>, 1723\u20131727 (2016).","DOI":"10.1248\/bpb.b16-00309"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Matsumoto T, Watanabe S, Kawamura R, Taguchi K, Kobayashi T. Epigallocatechin gallate attenuates ET-1-induced contraction in carotid artery from type 2 diabetic OLETF rat at chronic stage of disease. Life Sci.<\/i>, 118<\/b>, 200\u2013205 (2014).","DOI":"10.1016\/j.lfs.2013.11.016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Matsumoto T, Watanabe S, Yamada K, Ando M, Iguchi M, Taguchi K, Kobayashi T. Relaxation induced by atrial natriuretic peptide is impaired in carotid but not renal arteries from spontaneously hypertensive rats due to reduced BKCa channel activity. Biol. Pharm. Bull.<\/i>, 38<\/b>, 1801\u20131808 (2015).","DOI":"10.1248\/bpb.b15-00527"},{"key":"29","unstructured":"29) Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br. J. Pharmacol.<\/i>, 172<\/b>, 3980\u20134001 (2015)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Miyagawa K, Ohashi M, Yamashita S, Kojima M, Sato K, Ueda R, Dohi Y. Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats. J. Hypertens.<\/i>, 25<\/b>, 415\u2013421 (2007).","DOI":"10.1097\/HJH.0b013e3280115b96"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Matsumoto T, Ando M, Watanabe S, Iguchi M, Nagata M, Kobayashi S, Taguchi K, Kobayashi T. Tunicamycin-induced alterations in the vascular response in organ-cultured superior mesenteric arteries of rats. Biol. Pharm. Bull.<\/i>, 39<\/b>, 1475\u20131481 (2016).","DOI":"10.1248\/bpb.b16-00254"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) McCarthy CG, Wenceslau CF, Goulopoulou S, Ogbi S, Baban B, Sullivan JC, Matsumoto T, Webb RC. Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats. Cardiovasc. Res.<\/i>, 107<\/b>, 119\u2013130 (2015).","DOI":"10.1093\/cvr\/cvv137"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kanie N, Kamata K. Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL\/KsJ(db\/db) mice. Gen. Pharmacol.<\/i>, 35<\/b>, 311\u2013318 (2000).","DOI":"10.1016\/S0306-3623(02)00115-5"},{"key":"34","unstructured":"34) Guimar\u00e3es S, Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev.<\/i>, 53<\/b>, 319\u2013356 (2001)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Watts SW, Morrison SF, Davis RP, Barman SM. Serotonin and blood pressure regulation. Pharmacol. Rev.<\/i>, 64<\/b>, 359\u2013388 (2012).","DOI":"10.1124\/pr.111.004697"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Kanagy NL, Mecca TE, Webb RC. Arachidonate metabolites and serotonin contraction of femoral arteries from DOCA-salt hypertensive rats. Blood Press.<\/i>, 5<\/b>, 113\u2013120 (1996).","DOI":"10.3109\/08037059609062117"},{"key":"37","unstructured":"37) L\u00ed\u0161kov\u00e1 S, Petrov\u00e1 M, Karen P, Kune\u0161 J, Zicha J. Effects of aging and hypertension on the participation of endothelium-derived contracting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. Eur. J. Pharmacol.<\/i>, 667<\/b>, 265\u2013270 (2011)."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Mecca TE, Webb RC. Vaascular responses to serotonin in steroid hypertensive rats. Hypertension<\/i>, 6<\/b>, 887\u2013892 (1984).","DOI":"10.1161\/01.HYP.6.6.887"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Nishihira K, Yamashita A, Tanaka N, Moriguchi-Goto S, Imamura T, Ishida T, Kawashima S, Yamamoto R, Kitamura K, Asada Y. Serotonin induces vasoconstriction of smooth muscle cell-rich neointima through 5-hydroxytriptamine2A receptor in rabbit femoral arteries. J. Thromb. Haemost.<\/i>, 6<\/b>, 1207\u20131214 (2008).","DOI":"10.1111\/j.1538-7836.2008.02996.x"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Shi Y, Vanhoutte PM. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br. J. Pharmacol.<\/i>, 154<\/b>, 639\u2013651 (2008).","DOI":"10.1038\/bjp.2008.110"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Fujimoto S, Itoh T. Contraction and relaxation responses of femoral artery and aorta to norepinephrine in young rats. Gen. Pharmacol.<\/i>, 27<\/b>, 1355\u20131359 (1996).","DOI":"10.1016\/S0306-3623(96)00078-X"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Arribas S, Marin J, Ponte A, Balfagon G, Salaices M. Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension. J. Pharmacol. Exp. Ther.<\/i>, 270<\/b>, 520\u2013527 (1994).","DOI":"10.1016\/S0022-3565(25)22411-9"},{"key":"43","unstructured":"43) Ghimire K, Altmann HM, Straub AC, Isenberg JS. Nitric oxide: what\u2019s new to NO? Am. J. Physiol. Cell Physiol.<\/i>, 312<\/b>, C254\u2013C262 (2017)."},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Bomfim GF, Dos Santos RA, Oliveira MA, Giachini FR, Akamine EH, Tostes RC, Fortes ZB, Webb RC, Carvalho MH. Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. Clin. Sci.<\/i>, 122<\/b>, 535\u2013543 (2012).","DOI":"10.1042\/CS20110523"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Pannirselvam M, Wiehler WB, Anderson T, Triggle CR. Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products. Br. J. Pharmacol.<\/i>, 144<\/b>, 953\u2013960 (2005).","DOI":"10.1038\/sj.bjp.0706121"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Leung HS, Leung FP, Yao X, Ko WH, Chen ZY, Vanhoutte PM, Huang Y. Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery. Vascul. Pharmacol.<\/i>, 44<\/b>, 299\u2013308 (2006).","DOI":"10.1016\/j.vph.2006.01.010"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/12\/40_b17-00210\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T22:11:44Z","timestamp":1751062304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/12\/40_b17-00210\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00210","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2017]]}}}